Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-24 @ 11:54 PM
NCT ID:
NCT04344951
Eligibility Criteria:
Inclusion Criteria:
* Age 18 or older
* Both genders
* For women of childbearing age, they should use or be willing to use a double contraceptive method during the study. A urine pregnancy test to exclude pregnancy will be performed prior to study initiation.
* Written consent after information provided by the patient or the legal representative in the event that the patient cannot consent.
* Upper respiratory or lower respiratory tract infection, as in Annexes II and III respectively.
* Positive respiratory secretion test for SARS-CoV-2 virus by molecular techniques or positive blood IgM titers.
Exclusion Criteria:
* Under 18 years of age
* Denial of written consent
* Any patient case where it has been decided not to rejuvenate
* Serum AST values greater than 5 times the upper normal range
* QTc interval in rest electrocardiogram greater than 500msecs
* Pregnancy or lactation. Urgent pregnancy test to exclude pregnancy before inclusion in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT04344951
Study Brief:
Protocol Section:
NCT04344951